Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Austin Arrigo"'
Publikováno v:
Cancer Research. 83:2603-2603
The role of Tumor Suppressor Candidate 2 (TUSC2) in glioblastoma (GBM) is still poorly understood. Our recent study (Cancer Letters, 2022) reported, for the first time, that TUSC2 functions as a novel tumor suppressor for GBM. In this report, we foun
Publikováno v:
Cancer Lett
Transgenic breast cancer mouse models are critical tools for preclinical studies of human breast cancer. Genetic editing of the murine mammary gland allows for modeling of abnormal genetic events frequently found in human breast cancers. Genetically
Publikováno v:
Cancers. 15:2455
Tumor Suppressor Candidate 2 (TUSC2) was first discovered as a potential tumor suppressor gene residing in the frequently deleted 3p21.3 chromosomal region. Since its discovery, TUSC2 has been found to play vital roles in normal immune function, and
Autor:
Sherona R. Sirkisoon, Grace L. Wong, Noah R. Aguayo, Daniel L. Doheny, Dongqin Zhu, Angelina T. Regua, Austin Arrigo, Sara G. Manore, Calvin Wagner, Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui-Wen Lo
Publikováno v:
Cancer letters. 540
Mechanisms underlying breast cancer brain metastasis (BCBM) are still unclear. In this study, we observed that extracellular vesicles (EVs) secreted from breast cancer cells with increased expression of tGLI1, a BCBM-promoting transcription factor, s
Autor:
Sara G. Manore, Daniel L. Doheny, Dongqin Zhu, Grace L. Wong, Angelina T. Regua, Austin Arrigo, Calvin J. Wagner, Mariana Najjar, Hui-Wen Lo
Publikováno v:
Cancer Research. 82:92-92
Breast cancer is the most frequently diagnosed cancer and second leading cause of cancer-related deaths in women; 30% of primary breast cancer cases will develop distant metastases. The majority (90%) of breast cancer-related deaths are due to distan
Autor:
Angelina T. Regua, Dongqin Zhu, Daniel L. Doheny, Grace L. Wong, Sara G. Manore, Calvin J. Wagner, Austin Arrigo, Mariana Najjar, Hui-Wen Lo
Publikováno v:
Cancer Research. 82:1039-1039
Breast cancer is the most commonly diagnosed cancer in American women and accounts for ~15% of cancer-related deaths. Despite the current standard of care, metastatic HER2-enriched breast cancer and triple-negative breast cancer remain difficult to t
Autor:
Grace L. Wong, Sherona R. Sirkisoon, Noah R. Aguayo, Daniel L. Doheny, Dongqin Zhu, Angelina T. Regua, Austin Arrigo, Sara G. Manore, Calvin J. Wagner, Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui-Wen Lo
Publikováno v:
Cancer Research. 82:2354-2354
Breast cancer is the most frequently diagnosed cancer, and second most common source of brain metastasis in women. Despite recent advances in detection and therapeutics, patients with breast cancer brain metastases (BCBM) survive only 6-18 months aft
Autor:
Angelina T. Regua, Grace L. Wong, Austin Arrigo, Sara Abu Jalboush, Jiayuh Lin, Alexandra Thomas, Jimmy Ruiz, Roy E. Strowd, Sara G. Manore, Daniel Doheny, Yang Yu, Noah R. Aguayo, Dongqin Zhu, Calvin J. Wagner, Guangxu Jin, Peiqing Sun, Michael D. Chan, Hui-Wen Lo
Publikováno v:
Cancers
Cancers, Vol 13, Iss 2340, p 2340 (2021)
Volume 13
Issue 10
Cancers, Vol 13, Iss 2340, p 2340 (2021)
Volume 13
Issue 10
JAK2–STAT3 and TrkA signaling pathways have been separately implicated in aggressive breast cancers
however, whether they are co-activated or undergo functional interaction has not been thoroughly investigated. Herein we report, for the first
however, whether they are co-activated or undergo functional interaction has not been thoroughly investigated. Herein we report, for the first
Autor:
Karen Baylon, Roy E. Strowd, Noah R. Aguayo, Sara G. Manore, Austin Arrigo, Jiayuh Lin, Calvin J. Wagner, Sara Abu Jalboush, Grace L. Wong, Daniel L. Doheny, Angelina T. Regua, Linda J. Metheny-Barlow, Jimmy Ruiz, Dongqin Zhu, Yang Yu, Alexandra Thomas, Peiqing Sun, Michael D. Chan, Hui-Wen Lo, Guangxu Jin
Publikováno v:
Cancer Research. 81:1979-1979
Breast cancer is the leading cause of cancer-related deaths in American women. Despite the current standard-of-care, which implements tumor resection, radiotherapy, and chemotherapy, triple-negative and HER2-positive breast cancer patients often rela
Publikováno v:
Discovery medicine. 28(154)
Tropomyosin receptor kinases (TRKs) were first identified in 1986 when NTRK1 was discovered as part of an oncogenic fusion gene in colorectal cancer and the discovery of NTRK2 and NTRK3 followed shortly after. In the decades since their discovery, TR